WS Data Solutions
Discounted Cash Flow Rating
Strong Sell
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Neutral
Price to Earnings Rating
Strong Sell
Analyst Rating
Strong Sell
Simple Moving Average
Strong Buy
Exponential Moving Average
Strong Buy
Relative Strength Index
Neutral
Standard Deviation
Strong Buy
Williams %R
Strong Buy
Average Directional Index
Sell
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Neutral
B
Kymera Therapeutics, Inc. Common Stock (KYMR)
Biological Products, (no Disgnostic Substances)
Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.
200 ARSENAL YARDS BLVD., SUITE 230
WATERTOWN, MA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
08/21/2020
Market Cap
2,701,702,500
Shares Outstanding
59,370,000
Weighted SO
59,371,531
Total Employees
N/A
Upcoming Earnings
08/01/2024
Beta
2.2230
Last Div
0.0000
Range
9.6-48.7
Chg
-0.2900
Avg Vol
599720
Mkt Cap
2701702500
Exch
NASDAQ
Country
US
Phone
857 285 5300
DCF Diff
74.7058
DCF
-30.6658
Div Yield
0.0000
P/S
30.5105
EV Multiple
-15.8858
P/FV
4.6667
Div Yield %
0.0000
P/E
-20.2488
PEG
-1.9034
Payout
0.0000
Current Ratio
8.4548
Quick Ratio
8.4548
Cash Ratio
1.0880
DSO
7.0238
DIO
0.0000
Op Cycle
7.0238
DPO
460.0484
CCC
-453.0246
Gross Margin
0.9417
Op Margin
-2.0401
Pretax Margin
-1.7827
Net Margin
-1.7827
Eff Tax Rate
-0.0262
ROA
-0.1911
ROE
-0.2888
ROCE
-0.2365
NI/EBT
1.0000
EBT/EBIT
0.8738
EBIT/Rev
-2.0401
Debt Ratio
0.1068
D/E
0.1287
LT Debt/Cap
0.0996
Total Debt/Cap
0.1141
Int Coverage
-9508.0000
CF/Debt
-1.2035
Equity Multi
1.2060
Rec Turnover
51.9660
Pay Turnover
0.7934
Inv Turnover
0.0000
FA Turnover
0.8816
Asset Turnover
0.1072
OCF/Share
-1.4526
FCF/Share
-1.8878
Cash/Share
6.9800
OCF/Sales
-1.1985
FCF/OCF
1.2996
CF Coverage
-1.2035
ST Coverage
-8.5478
CapEx Coverage
-3.3380
Div&CapEx Cov
-3.3380
P/BV
4.6667
P/B
4.6667
P/S
30.5105
P/E
-20.2488
P/FCF
-19.5885
P/OCF
-30.1176
P/CF
-30.1176
PEG
-1.9034
P/S
30.5105
EV Multiple
-15.8858
P/FV
4.6667
DPS
0.0000